miR-335 Targets LRRK2 and Mitigates Inflammation in Parkinson's Disease.
Oliveira SR, Dionísio PA, Gaspar MM, Correia Guedes L, Coelho M, Rosa MM, Ferreira JJ, Amaral JD, Rodrigues CMP.
Oliveira SR, et al.
Front Cell Dev Biol. 2021 Jun 15;9:661461. doi: 10.3389/fcell.2021.661461. eCollection 2021.
Front Cell Dev Biol. 2021.
PMID: 34211970
Free PMC article.